Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 AUD | -25.00% | -25.00% | -14.29% |
25/03 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
14/03 | Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-14.29% | 83.75L | |
+26.37% | 4.82TCr | |
-1.01% | 4.17TCr | |
+43.79% | 4.1TCr | |
-5.31% | 2.88TCr | |
+9.34% | 2.56TCr | |
-21.69% | 1.9TCr | |
+6.23% | 1.29TCr | |
+26.99% | 1.2TCr | |
-3.38% | 1.18TCr |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Avecho Biotechnology Expands Research Partnership for Cannabidiol Medication